CTEP Branches and Offices
Last Updated: 08/28/20
Coronavirus Guidance
DCTD CTEP and NCORP Guidances
- Interim Guidance for Clinical Trial Activities Affected by the Novel Coronavirus (3/13/20)
- Additional Guidance Regarding Alternative Procedures for Clinical Trials Supported by NCI CTEP and NCORP Affected by the Spread of the Novel Coronavirus (3/23/20)
- CTEP/NCORP Guidance for Collection of Adverse Events Related to COVID-19 Infection (3/25/20)
- Updated Interim Guidance for Shipping Oral IND Agents to Clinical Trial Subjects during the COVID-19 Pandemic (8/28/20)
These guidelines complement and support the NCI CIRB Guidance for the novel coronavirus.
FDA Guidance
NIH Guidances
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 (Notice Number: NOT-OD-20-87)
- Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 (Notice Number: NOT-OD-20-86)
Additional important guidance may be added as it becomes available.